| 英文摘要 |
Objective: Debates regarding association or coincidence between nucleic acid-based vaccines and immune-mediated diseases following their vaccinations have been ongoing since the introduction of COVID-19 vaccines worldwide. However, epidemiological evidence of their influences on hard clinical endpoints is still lacking. Methods: We retrospectively screened medical charts for patients hospitalized to Taipei Veterans General Hospital (TVGH) for active autoimmune and autoinflammatory diseases between April 2021 and March 2022. They were mostly assigned to board-certified rheumatologists & immunologists in our hospital. Patients presenting with new-onset autoimmune and autoinflammatory diseases and receiving AZD1222, BNT-162b2, or mRNA-1273 within 180 days before the dates of admissions will be eligible. We hypothesized that hospitalizations following vaccinations are not random and the incubation periods would not distribute uniformly, assessed by two-tailed Kolmogorov-Smirnov test for goodness of fit. Results: The incubation periods from the last vaccinations to admissions are, in average, 53.8±31.1 (N = 38; median 54.5) days. The distribution of the incubation periods was not uniform as analysed by Kolmogorov-Smirnov test (p = 0.006). There were no hospitalizations after 150 days post-vaccination, and admissions of 31 (81.6%) patients clustered within 75 days post-vaccination over a 180-day observation period. Conclusions: Hospitalizations attributable to immunizations are rare events. Still, nucleic acid-based vaccines may potentially exert unwanted effects on the immune system of unfortunate individuals, leading to admissions for new-onset autoimmune/autoinflammatory diseases, mostly within 75 days postvaccination in our patients. Attention and cautions should be exercised among physicians upon relevant clinical scenarios. |